Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'Alzheimer''s Disease' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2813 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McEwen, BS
      Genome and hormones: Gender differences in physiology - Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Hass, S; Weidemann, A; Utermann, G; Baier, G
      Intracellular apolipoprotein E affects amyloid precursor protein processing and amyloid A beta production in COS-1 cells

      MOLECULAR GENETICS AND GENOMICS
    3. Nalivaeva, NN; Turner, AJ
      Post-translational modifications of proteins: Acetylcholinesterase as a model system

      PROTEOMICS
    4. Bieber, EJ; Cohen, DP
      Estrogens and hormone replacement therapy: Is there a role in the preservation of cognitive function?

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    5. Linn, ES; Kaunitz, AM; Schnare, S; Taylor, M
      The hormone continuum: Accrual of women's health benefits

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    6. Vielhaber, E; Virshup, DM
      Casein kinase I: From obscurity to center stage

      IUBMB LIFE
    7. Blauw, GJ; Bollen, ELEM; van Buchem, MA; Westendorp, RGJ
      Dementia at old age: a clinical end-point of atherosclerotic disease

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    8. Potkin, SG; Anand, R; Fleming, K; Alva, G; Keator, D; Carreon, D; Messina, J; Wu, JC; Hartman, R; Fallon, JH
      Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    9. Friedhoff, LT; Cullen, EI; Geoghagen, NSM; Buxbaum, JD
      Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    10. Joosten, E
      Homocysteine, vascular dementia and Alzheimer's disease

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    11. de Ceballos, ML; Brera, B; Fernandez-Tome, MP
      beta-Amyloid-induced cytotoxicity, peroxide generation and blockade of glutamate uptake in cultured astrocytes

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    12. Near, SE; Wang, J; Hegele, RA
      Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene

      JOURNAL OF HUMAN GENETICS
    13. Lautenschlager, NT; Riemenschneider, M; Drzezga, A; Kurz, AF
      Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging and biochemical findings

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    14. Scherder, E; Bouma, A; Slaets, J; Ooms, M; Ribbe, M; Blok, A; Sergeant, J
      Repeated pain assessment in Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    15. Liou, YJ; Lai, IC; Hong, CJ; Liu, HC; Liu, TY; Tsai, SJ
      Association analysis of the partially duplicated alpha 7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    16. Nicosia, F; Alberici, A; Benussi, L; Gasparini, L; Ghidoni, R; Mazzoli, F; Zanetti, O; Frisoni, GB; Geroldi, C; Binetti, G
      Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer'sdisease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    17. Tarkowski, E; Liljeroth, AM; Nilsson, A; Minthon, L; Blennow, K
      Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    18. Nebu, A; Ikeda, M; Fukuhara, R; Shigenobu, K; Maki, N; Hokoishi, K; Komori, K; Yasuoka, T; Tanabe, H
      Relationship between blood flow kinetics and severity of Alzheimer's disease: Assessment of severity using a questionnaire-type examination, Alzheimer's disease assessment scale, cognitive sub-scale (ADAS(cog))

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    19. Davidsson, P; Bogdanovic, N; Lannfelt, L; Blennow, K
      Reduced expression of amyloid precursor protein, presenilin-1 and rab3a incortical brain regions in Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    20. Sjogren, M; Davidsson, P; Gottfries, J; Vanderstichele, H; Edman, A; Vanmechelen, E; Wallin, A; Blennow, K
      The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    21. Swainson, R; Hodges, JR; Galton, CJ; Semple, J; Michael, A; Dunn, BD; Iddon, JL; Robbins, TW; Sahakian, BJ
      Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    22. Smith, MZ; Esiri, MM; Barnetson, L; King, E; Nagy, Z
      Constructional apraxia in Alzheimer's disease: Association with occipital lobe pathology and accelerated cognitive decline

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    23. Doody, RS; Dunn, JK; Clark, CM; Farlow, M; Foster, NL; Liao, T; Gonzales, N; Lai, E; Massman, P
      Chronic donepezil treatment is associated with slowed cognitive decline inAlzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    24. Pagani, M; Salmaso, D; Ramstrom, C; Jonsson, C; Lundqvist, R; Thurfjell, L; Schnell, PO; Wagner, A; Jacobsson, H; Larsson, SA
      Mapping pathological Tc-99m-d,I-hexamethylpropylene amine oxime uptake in Alzheimer's disease and frontal lobe dementia with SPECT

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    25. Imamura, T; Ishii, K; Hirono, N; Hashimoto, M; Tanimukai, S; Kazui, H; Hanihara, T; Sasaki, M; Mori, E
      Occipital glucose metabolism in dementia with Lewy bodies with and withoutparkinsonism: A study using positron emission tomography

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    26. Barber, R; McKeith, IG; Ballard, C; Gholkar, A; O'Brien, JT
      A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: Magnetic resonance imaging volumetric study

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    27. Sjobeck, M; Englund, E
      Alzheimer's disease and the cerebellum: A morphologic study on neuronal and glial changes

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    28. Yoo, BC; Cairns, N; Fountoulakis, M; Lubec, G
      Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin 1 in brain of patients with Down syndrome and Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    29. Okuda, B; Tachibana, H; Kawabata, K; Takeda, M; Sugita, M
      Comparison of brain perfusion in corticobasal degeneration and Alzheimer'sdisease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    30. Oremus, M; Wolfson, C; Perrault, A; Demers, L; Momoli, F; Moride, Y
      Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    31. Yamagata, K; Urakami, K; Ikeda, K; Ji, Y; Adachi, Y; Arai, H; Sasaki, H; Sato, K; Nakashima, K
      High expression of apolipoprotein e mRNA in the brains with sporadic Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    32. Scacchi, R; Gambina, G; Martini, MC; Ruggeri, M; Ferrari, G; Silvestri, M; Schiavon, R; Corbo, RM
      Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasmalipidic pattern

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    33. Aerssens, J; Raeymaekers, P; Lilienfeld, S; Geerts, H; Konings, F; Parys, W
      APOE genotype: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    34. Nobili, F; Copello, F; Buffoni, F; Vitali, P; Girtler, N; Bordoni, C; Safaie-Semnani, E; Mariani, G; Rodriguez, G
      Regional cerebral blood flow and prognostic evaluation in Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    35. Eckert, A; Oster, M; Zerfass, R; Hennerici, M; Muller, WE
      Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease - Specific differences to vascular dementia

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    36. Braunewell, KH; Riederer, P; Spilker, C; Gundelfinger, ED; Bogerts, B; Bernstein, HG
      Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (VILIPs)-1 and -3, in neocortical brain areas of Alzheimer disease patients

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    37. Yamada, M; Itoh, Y; Sodeyama, N; Suematsu, N; Otomo, E; Matsushita, M; Mizusawa, H
      Senile dementia of the neurofibrillary tangle type: A comparison with Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    38. Blomberg, M; Jensen, M; Basun, H; Lannfelt, L; Wahlund, LO
      Cerebrospinal fluid tau levels increase with age in healthy individuals

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    39. McCaddon, A; Hudson, P; Abrahamsson, L; Olofsson, H; Regland, B
      Analogues, ageing and aberrant assimilation of vitamin B12 in Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    40. Lesser, G; Kandiah, K; Libow, LS; Likourezos, A; Breuer, B; Marin, D; Mohs, R; Haroutunian, V; Neufeld, R
      Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    41. Leuba, G; Saini, K; Zimmermann, V; Giannakopoulos, P; Bouras, C
      Mild amyloid pathology in the primary visual system of nonagenarians and centenarians

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    42. Nebu, A; Ikeda, M; Fukuhara, R; Komori, K; Maki, N; Hokoishi, K; Shigenobu, K; Kikuchi, T; Tanabe, H
      Utility of Tc-99m-HM-PAO SPECT hippocampal image to diagnose early stages of Alzheimer's disease using semiquantitative analysis

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    43. Novella, JL; Ankri, J; Morrone, I; Guillemin, F; Jolly, D; Jochum, C; Ploton, L; Blanchard, F
      Evaluation of the quality of life in dementia with a generic quality of life questionnaire: The Duke Health Profile

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    44. Power, DA; Noel, J; Collins, R; O'Neill, D
      Circulating leptin levels and weight loss in Alzheimer's disease patients

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    45. Kawano, M; Ichimiya, A; Ogomori, K; Kuwabara, Y; Sasaki, M; Yoshida, T; Tashiro, N
      Relationship between both IQ and Mini-Mental State Examination and the regional cerebral glucose metabolism in clinically diagnosed Alzheimer's disease: A PET study

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    46. Brane, G; Gottfries, CG; Winblad, B
      The Gottfries-Brane-Steen Scale: Validity, reliability and application in anti-dementia drug trials

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    47. Hirono, N; Mori, E; Ishii, K; Imamura, T; Tanimukai, S; Kazui, H; Hashimoto, M; Takatsuki, Y; Kitagaki, H; Sasaki, M
      Neuronal substrates for semantic memory: A positron emission tomography study in Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    48. Almkvist, O; Jelic, V; Amberla, K; Hellstrom-Lindahl, E; Meurling, L; Nordberg, A
      Responder characteristics to a single oral dose of cholinesterase inhibitor: A double-blind placebo-controlled study with tacrine in Alzheimer patients

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    49. Neill, D; Hughes, D; Leake, A; Morris, C; Jones, D; Oakley, A; Edwardson, J; Estibeiro, P
      Neuritogenic-neurotoxic effects of membrane-associated forms of amyloid precursor protein

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    50. Broadley, KJ; Kelly, DR
      Muscarinic receptor agonists and antagonists

      MOLECULES
    51. Huse, JT; Doms, RW
      Neurotoxic traffic: Uncovering the mechanics of amyloid production in Alzheimer's disease

      TRAFFIC
    52. Daugherty, BL; Green, SA
      Endosomal sorting of amyloid precursor protein-P-selectin chimeras influences secretase processing

      TRAFFIC
    53. Watanabe, K; Segawa, T; Nakamura, K; Kodaka, M; Konakahara, T; Okuno, H
      Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay

      JOURNAL OF PEPTIDE RESEARCH
    54. Linner, E; Popovic, V; Gottfries, CG; Jonsson, M; Sjogren, M; Wallin, A
      The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    55. Kergoat, H; Kergoat, MJ; Justino, L; Chertkow, H; Robillard, A; Bergman, H
      An evaluation of the retinal nerve fiber layer thickness by scanning laserpolarimetry in individuals with dementia of the Alzheimer type

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    56. Dukic-Stefanovic, S; Schinzel, R; Riederer, P; Munch, G
      AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?

      BIOGERONTOLOGY
    57. Studer, R; Baysang, G; Brack, C
      N-acetyl-L-cystein downregulates ss-amyloid precursor protein gene transcription in human neuroblastoma cells

      BIOGERONTOLOGY
    58. Petrosian, AA; Prokhorov, DV; Lajara-Nanson, W; Schiffer, RB
      Recurrent neural network-based approach for early recognition of Alzheimer's disease in EEG

      CLINICAL NEUROPHYSIOLOGY
    59. Liepert, J; Bar, KJ; Meske, U; Weiller, C
      Motor cortex disinhibition in Alzheimer's disease

      CLINICAL NEUROPHYSIOLOGY
    60. Matousek, M; Brunovsky, M; Edman, A; Wallin, A
      EEG abnormalities in dementia reflect the parietal lobe syndrome

      CLINICAL NEUROPHYSIOLOGY
    61. Jeong, J; Gore, JC; Peterson, BS
      Mutual information analysis of the EEG in patients with Alzheimer's disease

      CLINICAL NEUROPHYSIOLOGY
    62. Parisi, V; Restuccia, R; Fattapposta, F; Mina, C; Bucci, MG; Pierelli, F
      Morphological and functional retinal impairment in Alzheimer's disease patients

      CLINICAL NEUROPHYSIOLOGY
    63. Santiard-Baron, D; Lacoste, A; Ellouk-Achard, S; Soulie, C; Nicole, A; Sarasin, A; Ceballos-Picot, I
      The amyloid peptide induces early genotoxic damage in human preneuron NT2

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    64. Small, G
      Meeting the challenges of vascular dementia - Introduction

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    65. Roman, G
      Diagnosis of vascular dementia and Alzheimer's disease

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    66. Maelicke, A
      The pharmacological rationale for treating vascular dementia with galantamine (Reminyl(Tau Mu))

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    67. Gauthier, S; Ferris, S
      Outcome measures for probable vascular dementia and Alzheimers disease with cerebrovascular disease

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    68. Salib, E; Sheridan, T; Allington, M
      Ventricular measurements in computed tomography of responders and non-responders to donepezil in the treatment of Alzheimer's disease

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    69. Fountoulakis, KN; Tsolaki, M; Kazis, A
      Investigation of 'borderline' dementia, particularly of Alzheimer's type, compared with non-demented patients with similar neuropsychological profiles

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    70. Mattson, MP; Duan, W; Pedersen, WA; Culmsee, C
      Neurodegenerative disorders and ischemic brain diseases

      APOPTOSIS
    71. Zubenko, GS; Hughes, HB; Stiffler, JS
      D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals

      MOLECULAR PSYCHIATRY
    72. Kunugi, H; Ueki, A; Otsuka, M; Isse, K; Hirasawa, H; Kato, N; Nabika, T; Kobayashi, S; Nanko, S
      A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease

      MOLECULAR PSYCHIATRY
    73. Fleischman, DA; Monti, LA; Dwornik, LM; Moro, TT; Bennett, DA; Gabrieli, JDE
      Impaired production priming and intact identification priming in Alzheimer's disease

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    74. Vanderploeg, RD; Yuspeh, RL; Schinka, JA
      Differential episodic and semantic memory performance in Alzheimer's disease and vascular dementias

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    75. Albert, MS; Moss, MB; Tanzi, R; Jones, K
      Preclinical prediction of AD using neuropsychological tests

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    76. Razani, J; Boone, KB; Miller, BL; Lee, A; Sherman, D
      Neuropsychological performance of right- and left-frontotemporal dementia compared to Alzheimer's disease

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    77. Norton, LE; Ostergaard, AL
      Priming performance in Alzheimer's disease: The role of task sensitivity

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    78. Fama, R; Shear, PK; Marsh, L; Yesavage, JA; Tinklenberg, JR; Lim, KO; Pfefferbaum, A; Sullivan, EV
      Remote memory for public figures in Alzheimer's disease: Relationships to regional cortical and limbic brain volumes

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    79. O'Brien, J; Robinson, L; Fairbairn, A
      Proposed shared care protocol between primary and secondary care for the ongoing management of those on anti-dementia medication

      PRIMARY CARE PSYCHIATRY
    80. Rausch, DM; Davis, MR
      HIV in the CNS: Pathogenic relationships to systemic HIV disease and otherCNS diseases

      JOURNAL OF NEUROVIROLOGY
    81. Danysz, W
      Neurotoxicity as a mechanism for neurodegenerative disorders: Basic and clinical aspects - March 16-18th 2001, Pucon, Chile

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    82. Emre, M; Qizilbash, N
      Experimental approaches and drugs in development for the treatment of dementia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS

    83. Peroxynitrile decomposition catalysts and methods of use thereof

      EXPERT OPINION ON THERAPEUTIC PATENTS
    84. Stoessl, AJ
      Antisense strategies for the treatment of neurological disease

      EXPERT OPINION ON THERAPEUTIC PATENTS
    85. Joyce, JN; Ryoo, H; Gurevich, EV; Adler, C; Beach, T
      Ventral striatal D-3 receptors and Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    86. Bowirrat, A; Treves, TA; Friedland, RP; Korczyn, AD
      Prevalence of Alzheimer's type dementia in an elderly Arab population

      EUROPEAN JOURNAL OF NEUROLOGY
    87. Siri, A; Benaglio, I; Frigerio, A; Binetti, G; Cappa, SF
      A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    88. Moretti, R; Torre, P; Antonello, RM; Cazzato, G
      Headache in dementia

      EUROPEAN JOURNAL OF NEUROLOGY
    89. Heo, HJ; Cho, HY; Hong, BS; Kim, HK; Kim, EK; Kim, BG; Shin, DH
      Protective effect of 4 ',5-dihydroxy-3 ',6,7-trimethoxyflavone from Artemisia asiatica against A beta-indueed oxidative stress in PC12 cells

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    90. Dominguez, DI; De Strooper, B; Annaert, W
      Secretases as therapeutic targets for the treatment of Alzheimer's disease

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    91. Yang, DS; Serpell, LC; Yip, CM; McLaurin, J; Chrishti, MA; Horne, P; Boudreau, L; Kisilevsky, R; Westaway, D; Fraser, PE
      Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    92. Gervais, F; Chalifour, R; Garceau, D; Kong, XQ; Laurin, J; McLaughlin, R; Morissette, C; Paquette, J
      Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    93. Rebeck, GW; Cho, HS; Grabowski, TJ; Greenberg, SM
      The effects of A beta PP mutations and APOE polymorphisms on cerebral amyloid angiopathy

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    94. Kim, HC; Kim, DK; Choi, IJ; Kang, KH; Yi, SD; Park, J; Park, YN
      Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    95. Yamada, T; Hattori, H; Miura, A; Tanabe, M; Yamori, Y
      Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    96. Lamb, HM; Goa, KL
      Rivastigmine - A pharmacoeconomic review of its use in Alzheimer's disease

      PHARMACOECONOMICS
    97. Martin, LJ
      Neuronal cell death in nervous system development, disease, and injury (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    98. Yang, JD; Feng, GY; Zhang, J; Hui, Z; Breen, G; Clair, DS; He, L
      Is ApoE gene a risk factor for vascular dementia in Han Chinese?

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    99. Foster, JK
      Selective attention in Alzheimer's disease

      FRONTIERS IN BIOSCIENCE
    100. Swertfeger, DK; Hui, DY
      Apolipoprotein E: A cholesterol transport protein with lipid transport-independent cell signaling properties

      FRONTIERS IN BIOSCIENCE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 02:29:10